A new antiplatelet drug, E5510, has multiple suppressive sites during receptor-mediated signal transduction in human platelets - Fujimori, T; Harada, K; Saeki, T; Kogushi, M; Yoshimura, T; Katayama, K (Jpn J Pharmacol, 1991)